Investigation of Pneumocystis jirovecii colonization in patients with chronic pulmonary diseases in the People's Republic of China
- PMID: 26491278
- PMCID: PMC4598221
- DOI: 10.2147/COPD.S89666
Investigation of Pneumocystis jirovecii colonization in patients with chronic pulmonary diseases in the People's Republic of China
Abstract
Background: The detection of Pneumocystis jirovecii DNA in respiratory specimen from individuals who do not have signs or symptoms of pneumonia has been defined as colonization. The role of P. jirovecii colonization in the development or progression of various lung diseases has been reported, but little information about P. jirovecii colonization in patients is available in the People's Republic of China.
Objective: To determine the prevalence of P. jirovecii colonization in patients with various pulmonary diseases, including the acute and stable stage of COPD, interstitial lung diseases, cystic fibrosis, and chronic bronchiectasis.
Materials and methods: A loop-mediated isothermal amplification (LAMP) and a conventional polymerase chain reaction (PCR) method for detecting P. jirovecii were developed. Ninety-eight HIV-negative patients who were followed-up and who had undergone bronchoscopy for diagnosis of various underlying respiratory diseases were included in the study. Sputa of these patients were analyzed with LAMP amplification of P. jirovecii gene. In addition, conventional PCR, Giemsa and Gomori's methenamine silver nitrate staining assays were applied to all specimens.
Results: The sensitivity and specificity test showed that there was no cross-reaction with other fungi or bacteria in detecting the specific gene of P. jirovecii by LAMP, and the minimum detection limits by LAMP was 50 copies/mL. P. jirovecii DNA was detected in 62 of 98 (63.3%) sputa specimens by LAMP assay and 22.45% (22/98) by conventional PCR. However, no P. jirovecii cysts were found by Giemsa and Gomori's methenamine silver nitrate in all of gene-positive specimens.
Conclusion: The results of our study showed that prevalence of P. jirovecii colonization is particularly high in patients with chronic pulmonary diseases in the People's Republic of China, and the LAMP method is better for evaluation of the colonization of P. jirovecii in sputum specimen than conventional PCR.
Keywords: Pneumocystis jirovecii; chronic pulmonary diseases; colonization; loop-mediated isothermal amplification.
Figures


Similar articles
-
[Investigation of Pneumocystis jirovecii colonization in patients with pulmonary diseases].Turkiye Parazitol Derg. 2014 Dec;38(4):214-9. doi: 10.5152/tpd.2014.3611. Turkiye Parazitol Derg. 2014. PMID: 25732877 Turkish.
-
Pneumocystis jirovecii colonization and its association with pulmonary diseases: a multicenter study based on a modified loop-mediated isothermal amplification assay.BMC Pulm Med. 2020 Mar 20;20(1):70. doi: 10.1186/s12890-020-1111-4. BMC Pulm Med. 2020. PMID: 32197601 Free PMC article.
-
[Investigation of Pneumocystis jirovecii pneumonia and colonization in iatrogenically immunosuppressed and immunocompetent patients].Mikrobiyol Bul. 2015 Apr;49(2):221-30. doi: 10.5578/mb.9344. Mikrobiyol Bul. 2015. PMID: 26167822 Turkish.
-
The prevalence of laboratory-confirmed Pneumocystis jirovecii in HIV-infected adults in Africa: A systematic review and meta-analysis.Med Mycol. 2021 Jul 14;59(8):802-812. doi: 10.1093/mmy/myab002. Med Mycol. 2021. PMID: 33578417 Free PMC article.
-
Pneumocystis jirovecii in Patients With Cystic Fibrosis: A Review.Front Cell Infect Microbiol. 2020 Sep 29;10:571253. doi: 10.3389/fcimb.2020.571253. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 33117730 Free PMC article. Review.
Cited by
-
Detection of Pneumocystis jirovecii and Toxoplasma gondii in patients with lung infections by a duplex qPCR assay.PLoS Negl Trop Dis. 2021 Dec 17;15(12):e0010025. doi: 10.1371/journal.pntd.0010025. eCollection 2021 Dec. PLoS Negl Trop Dis. 2021. PMID: 34919557 Free PMC article.
-
Alterations of lung microbiota in lung transplant recipients with pneumocystis jirovecii pneumonia.Respir Res. 2024 Mar 14;25(1):125. doi: 10.1186/s12931-024-02755-9. Respir Res. 2024. PMID: 38486264 Free PMC article.
-
Pneumocystis jirovecii Pneumonia-Associated Acute Respiratory Distress Syndrome Complicated by Pneumomediastinum and Pneumopericardium in a Non-Human Immunodeficiency Virus-Infected Patient.J Clin Med Res. 2020 Mar;12(3):209-213. doi: 10.14740/jocmr4074. Epub 2020 Mar 2. J Clin Med Res. 2020. PMID: 32231758 Free PMC article.
-
Clinical Characteristics and Prognostic Predictors of Pneumocystis Jirovecii Pneumonia in Patients with and without Chronic Pulmonary Disease: A Retrospective Cohort Study.Infect Drug Resist. 2024 May 30;17:2169-2182. doi: 10.2147/IDR.S456716. eCollection 2024. Infect Drug Resist. 2024. PMID: 38832106 Free PMC article.
-
Genetic Polymorphisms of Pneumocystis jirovecii in HIV-Positive and HIV-Negative Patients in Northern China.Pol J Microbiol. 2022 Feb 23;71(1):27-34. doi: 10.33073/pjm-2022-002. Pol J Microbiol. 2022. PMID: 35635165 Free PMC article.
References
-
- Riebold D, Enoh DO, Kinge TN, et al. Pneumocystis jirovecii colonisation in HIV-positive and HIV-negative subjects in Cameroon. Trop Med Int Health. 2014;19(6):643–655. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical